Case Report of Hepatic Epithelioid Hemangioendothelioma
Author Information
Author(s): Wang Jing-Rui, Yang Qi-Jun, Lu Bei, Cai Yang, Yin Jun-Jie
Primary Institution: Affiliated Hangzhou First People’s Hospital, Westlake University, School of Medicine, Hangzhou, China
Conclusion
The patient with hepatic epithelioid hemangioendothelioma showed no tumor progression after treatment with anlotinib over a 5-year follow-up.
Supporting Evidence
- The patient developed recurrent intrahepatic metastasis of the tumor after 5 years.
- Anlotinib treatment showed no tumor progression after 3 months.
Takeaway
This study talks about a 69-year-old woman with a rare liver tumor who was treated and monitored for 5 years, showing that her tumor didn't get worse after treatment.
Methodology
The patient was treated with transcatheter arterial chemoembolization and anlotinib, with follow-up imaging to assess tumor progression.
Limitations
The study is based on a single case report, limiting the generalizability of the findings.
Participant Demographics
The patient was a 69-year-old female with no significant comorbidities.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website